PHUSE SDE2016presentation·SDE·Single Day EventCDISC Therapeutic Area Standards Overview SHANGHAI01 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventIntroduction of Programming and Submission Considerations for Diabetes in Women’s Health Studies SHANGHAI02 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventConvert Complicated Study Design into DATA SHANGHAI03 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventStatistical Analysis in Rheumatoid Arthritis Trials SHANGHAI04 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventThe Relationship Between EDC Database Structure and SAS Dataset SHANGHAI05 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventAccelerate Drug Development from Lab to Fab with Design and Analysis of Experiments SHANGHAI07 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventRetina Trials: Design, Analysis and Challenges SHANGHAI08 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventFDA-specific data Standard Requirements for HCV Studies SHANGHAI10 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventAn Efficient Path for eCRF Annotation SHANGHAI11 APAC · ShanghaiSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventFDA Study Data Standardization Plan & Study Data Reviewer’s Guide TOKYO01 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventSEND Experiences are Bipolar in Japan TOKYO02 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventSEND Implementation in Japanese Pharmaceutical Companies and the JPMA's Involvement TOKYO03 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventSeminar: Overview of SEND-related Activities in Japan: Legacy Data/FDA Trial Submission TOKYO04 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventSuccessful SEND Compliance for Pharmaceutical Companies TOKYO05 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventMy Personal Experience: Self-creation of SEND Data Set TOKYO06 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventSEND for Pathologists and Toxicologists: Current Issues of SEND Data Conversion from Toxicologic Pathology Point of View TOKYO07 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventInter-organizational SEND Model in Japan: CRO-Sponsor Collaboration for SEND TOKYO08 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventFDA SEND Submissions: Does the Pinnacle 21 Open-source Community Validator Predict Findings from FDA SEND Validators? TOKYO09 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventPerspectives on Electronic Nonclinical Data Submission in Japan TOKYO10 APAC · TokyoSee metadata
PHUSE SDE2016presentation·SDE·Single Day EventFlip the Coin: The Next Epoch of Drug Development TRIVANDRUM01 APAC · TrivandrumSee metadata